Your browser doesn't support javascript.
loading
Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia.
Cathelin, Severine; Sharon, David; Subedi, Amit; Cojocari, Dan; Phillips, Darren C; Leverson, Joel D; MacBeth, Kyle J; Nicolay, Brandon; Narayanaswamy, Rohini; Ronseaux, Sebastien; Liu, Guowen; Chan, Steven M.
Afiliação
  • Cathelin S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Sharon D; Oncology Discovery, AbbVie Inc., North Chicago, IL, USA.
  • Subedi A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Cojocari D; Oncology Discovery, AbbVie Inc., North Chicago, IL, USA.
  • Phillips DC; Oncology Discovery, AbbVie Inc., North Chicago, IL, USA.
  • Leverson JD; Oncology Development, AbbVie Inc., North Chicago, IL, USA.
  • MacBeth KJ; Bristol Myers Squibb, Summit, NJ, USA.
  • Nicolay B; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Narayanaswamy R; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Ronseaux S; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Liu G; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Chan SM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. steven.chan@uhnresearch.ca.
Leukemia ; 36(3): 869-872, 2022 03.
Article em En | MEDLINE | ID: mdl-34743189

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Triazinas / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes / Inibidores Enzimáticos / Aminopiridinas / Isocitrato Desidrogenase / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Triazinas / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes / Inibidores Enzimáticos / Aminopiridinas / Isocitrato Desidrogenase / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article